The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients

Liknande verk

• Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
  av: Ikeda, T, et al.
  Publicerad: (2004)
• Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
  av: Ikeda, T, et al.
  Publicerad: (2005)
• Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
  av: Kase, Y, et al.
  Publicerad: (2009)
• Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections
  av: Ikeda, T, et al.
  Publicerad: (2000)
• Is it true that PMX-DHP can improve lung oxygenation?
  av: Ikeda, T, et al.
  Publicerad: (2003)